Share
1,009 Posts.
lightbulb Created with Sketch. 175
clock Created with Sketch. 12/06/25
16:39
Share
Originally posted by mondyinvest:
↑
It's a chart from the ASX website. And I mistyped the bit about profit and loss which is why I immediately corrected it. The chart shows that there's not been any real trend in the earnings (which is largely to be expected for a healthcare company trying to grow coming out of a global pandemic - this is not PNV's fault). All I'm noting is that I, and likely other investors, want to see a better trend in the earnings, i.e. the old jaws of operational leverage opening up. The $10M turnaround you highlight in 2024 was in large part due to a $3.55M income tax benefit. The financials show that before that benefit, they did -$4.93M in FY23 and +$1.7M in 2024. It is going the right way, but the FY25 result will be pretty important to see where the trend goes from here. I suspect many feel this way which is likely why, after the trading updates earlier in the year, the stock has fallen to these levels and not bounced back quickly. All eyes on their upcoming results. Consensus currently has them doing $7.6M NPAT.
Expand
What will the NPAT be in 12 months when sales and Barda are said by Macquarie to be $160m and $206m the following year.
(20min delay)